GWPH - GW Pharmaceuticals plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/20189/30/20189/30/20179/30/2016
Total Revenue26,61612,7378,62912,730
Cost of Revenue46,41640,7084,5213,820
Gross Profit-19,800-27,9714,1088,910
Operating Expenses
Research Development77,244119,014112,249104,375
Selling General and Administrative196,332141,81858,02033,188
Non Recurring----
Others----
Total Operating Expenses319,992301,540174,790141,383
Operating Income or Loss-293,376-288,803-166,161-128,653
Income from Continuing Operations
Total Other Income/Expenses Net4,688-2,567-5,33036,264
Earnings Before Interest and Taxes-293,376-288,803-166,161-128,653
Interest Expense-1,180-1,249-951-244
Income Before Tax-288,688-291,370-171,491-92,389
Income Tax Expense-1,0643,797-1,032-693
Minority Interest----
Net Income From Continuing Ops-287,624-295,167-170,459-91,696
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-287,624-295,167-170,459-91,696
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-287,624-295,167-170,459-91,696